Pfizer Animal Health

Get more information about a specific species.


MITABAN®
(amitraz)
Liquid Concentrate

Might Against Mites

Indications


MITABAN® (amitraz) Liquid Concentrate is indicated for treatment of generalized demodicosis (Demodex canis).

Key Features

  • Consistently effective: the treatment of choice for many years

  • Dated product assures guaranteed potency
Packaging

10.6-mL bottles

Dosage/Administration

Long- and medium-haired dogs should be clipped closely before treatment. Before the initial treatment, all dogs should be bathed with a mild soap and water and towel dried. The entire animal should then be topically treated with MITABAN (amitraz) at a rate of 10.6 mL (contents of one bottle) per 2 gallons of warm water (250 ppm active drug). Two bottles (21.2 mL) per 4 gallons of water may be necessary to treat large dogs. The entire dog should be thoroughly and completely wetted with the mixture and then allowed to air dry. Do not rinse or towel dry the dog after treatment with MITABAN. A fresh mixture of MITABAN and water should be prepared for each patient. Using the same mixture for more than one patient can spread other dermal infections and reduce the concentration of MITABAN to a level that would be less effective.

Three to six topical treatments (14 days apart) are recommended for treatment of generalized demodicosis. It is important to continue the treatment until no viable (live) mites are found in the skin scrapings at two successive treatments, or until six treatments have been applied. Severe (chronic) cases and dogs that are reinfested may require a second and third series of treatments and, again, the treatment should be applied at 14-day intervals. Discontinue treatment of dogs that do not respond clinically.

Precautions

When MITABAN is being used for treatment of demodicosis, other dogs in the home should be examined for lesions to ascertain whether treatment of these animals is warranted.

Current data do not support use for treatment of localized demodicosis or scabies.

Transient sedation may occur after treatment with this product. Safety for pregnant animals or dogs less than four months of age has not been established.

Avoid handling pets immediately after treatment. Contact may cause skin irritation in sensitive individuals during the first few days after treatment.

For topical use only.

For use in animals only.

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Product Information
Material Safety Data Sheet

entire article (printer friendly)

Locate a Product

Use the menus below to find product information.

 View all PfizerAH Dogs products

Locate a Product

There are no scheduled
events listed at this time.

Search
 
Advanced Search




Copyright © 2010 Pfizer Inc. All rights reserved.


The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.

The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.